Keywords
diabetes mellitus
hypertension
hypercholesterolemia
body mass index
dyslipidemia
How to Cite
Abstract
Background: The relationship between hypothyroidism and chronic-degenerative diseases has been documented.
Purpose: To determine the prevalence of chronic degenerative diseases in young adults (25-44 years) with hypothyroidism.
Methodology: Descriptive cross-sectional design in young adults aged 25 to 44 years with a diagnosis of hypothyroidism established by thyroid-stimulating hormone values. The total sample calculated corresponded to 266, however, the total of the existing files in the medical unit (n=200) was used. A sampling technique was not used because all existing records were included. The diagnosis of chronic degenerative disease was determined with information from the clinical file; biochemical variables included thyroid-stimulating hormone, fasting serum glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides; Systolic and diastolic blood pressure and body mass index were also recorded. The statistical analysis included averages, confidence intervals for averages, percentages, and confidence intervals for percentages.
Results: The prevalence of diabetes was 14.0% (95% CI; 9.1-18.8), hypertension 14.5% (95% CI; 9.5-19.4), dyslipidemia 55.5% (95% CI; 48.5-62.5), and obesity 50.0% (95% CI; 41.3-56.9).
Conclusions: Dyslipidemia and obesity are the chronic diseases with the highest prevalence in young adults with hypothyroidism.
References
Cooper DS, Ladenson PW. Capítulo 7: la glándula tiroides. En Gardner DG, Shoback D, editores. Endocrinología básica y clínica. 10.a ed. McGraw-Hill; 2018.
Mancillo-Conforme AJ, Medina-Reyes GL, Ponce-Pincaya RA. Prevalencia de trastornos tiroideos en pacientes atendidos en el Instituto de Seguridad Social Jipijapa. MQRInvestigar. 2025;9(1):e85. https://doi.org/10.56048/MQR20225.9.1.2025.e85
Trifu DS, Gil-Fournier Esquerra N, Peláez Torres N, Álvarez Hernández J. Hipotiroidismo. Medicine, 2020;13(13):727-34. https://doi.org/10.1016/j.med.2020.07.003
Vargas-Uricoechea H, Builes-Barrera C, Arenas-Quintero H, Castellanos-Pinedo A, Restrepo-Erazo K, Duque-Ossman JJ, et al. Consenso colombiano para el diagnóstico, el tratamiento y el seguimiento del hipotiroidismo en población adulta. Rev Colomb Endocrinol Diabet Metab. 2023;10(4):e818. https://doi.org/10.53853/encr.10.4.818
Hughes K, Eastman C. Thyroid disease: long-term management of hyperthyroidism and hypothyroidism. Aust J Gen Pract. 2021;50(1-2):36-42. https://doi.org/10.31128/ajgp-09-20-5653
Pinela Gonzabay FI, Merchán Villafuerte K. Hipotiroidismo e hipertensión: una revisión sistemática en América Latina. Pentaciencias, 2022;4(4):1-22. https://www.editorialalema.org/index.php/pentaciencias/article/view/215
Quintana Marrero A, López Medina GG, Rivas Alpízar EM, González Ramos JO. Disfunción tiroidea en pacientes con diabetes mellitus tipo 2. Rev Finaly. 2020;10(3):222-30. http://www.revfinlay.sld.cu/index.php/finlay/article/view/847
Magallanes Borbor M, Cadena Alvarado J, Riofrio Baque R, Carriel Alvarez M. Anticuerpos antitiroideos como factor asociado al desarrollo de hipotiroidismo en mujeres con diabetes mellitus tipo 2. Pentaciencias. 2022;4(3):473-83. https://editorialalema.org/index.php/pentaciencias/article/view/175
Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, Moreno-Banda GL, Carnalla M, et al. Prevalencia de prediabetes y diabetes en México: Ensanut 2022. Salud Pública Mex. 2023;65:163-8. https://doi.org/10.21149/14832
Gordillo Iñiguez AM, Mogrovejo Palacios DR. Influencia del hipotiroidismo e hipertiroidismo en el desarrollo de enfermedad cardiovascular. Cambios Rev Méd. 2019;18(2):13-7. https://doi.org/10.36015/cambios.v18.n2.2019.533
Instituto Mexicano del Seguro Social. Diagnóstico y tratamiento de la hipertensión arterial en el primer nivel de atención. México: Cenetec; 2014. https://www.imss.gob.mx/sites/all/statics/guiasclinicas/076GER.pdf
Ortiz Galeano I, Pedrozo HB, López Overlar HMR. Hipotiroidismo como factor de riesgo de dislipidemia y obesidad. Rev Virtual Soc Parag Med Int. 2020;7(2):55-61. https://doi.org/10.18004/rvspmi/2312-3893/2020.07.02.55
Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr Rev. 2019;40(3):789-824. https://doi.org/10.1210/er.2018-00163
Trasancos Delgado M, Casanova Moreno MC. Capacitación en enfermedades tiroideas: una necesidad en los proveedores de salud. Edumecentro. 2018;10(1):243-7. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2077-28742018000100018&lng=es
Liu H, Peng D. Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism. Endocr Connect. 2022;11(2):e210002. https://doi.org/10.1530/ec-21-0002
Walczak K, Seiminska L. Obesity and thyroid axis. Int J Environ Res Public Health. 2021;18(18):9434. https://doi.org/10.3390/ijerph18189434
Escobedo-de la Peña J, Pérez RJ, Schargrodsky H, Champagne B. Prevalencia de dislipidemias en la ciudad de México y su asociación con otros factores de riesgo cardiovascular. Resultados del estudio CARMELA. Gaceta Médica de México, 2014;150:128-36.
Franco-Herrera D, Córdoba Díaz D, González Ocampo D, Ospina JJ, Olaya Garay SX, Murillo García DR. Hipertiroidismo en el embarazo. Rev Peru Ginecol Obstet. 2018;64(4):569-79. https://doi.org/10.31403/rpgo.v64i2125
Roa Dueñas OH, Van der Burgh AC, Ittermann T, Lighart S, Ikram MA, Peeters R, et al. Thyroid function and the risk of prediabetes and type 2 diabetes. J Clin Endocrinol Metab. 2022;107(6):1789-98. https://doi.org/10.1210/clinem/dgac006
Bohórquez Moreno CE, Barreto Vásquez M, Muvdi Muvdi YP, Rodríguez Sanjuán A, Badillo Viloria MA, Martínez de la Rosa WÁ, et al. Factores modificables y riesgo de diabetes mellitus tipo 2 en adultos jóvenes: un estudio transversal. Cienc Enferm. 2020;26:14. http://dx.doi.org/10.29393/ce26-7fmcb70007
Instituto Mexicano del Seguro Social. Diagnóstico y tratamiento del sobrepeso y obesidad exógena. México: Cenetec; 2018. https://www.imss.gob.mx/sites/all/statics/guiasclinicas/046GER.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Revista Colombiana de Endocrinología, Diabetes & Metabolismo